SCHEMBL21912296

SCHEMBL21912296

CCOC(=O)C(=N)c1csc(-n2ccnc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MITF O75030 1/20 0.45
CHEK1 O14757 1/20 0.40
GAA P10253 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
BLM P54132 1/20 0.35
ESR2 Q92731 1/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5868906 0.85 RAB9A (0.51) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL3563236 0.76 CHEK1 (0.47) MAPTCHEK1NPC1RAB9ALMNA
SCHEMBL31216581 0.76 HTT (0.50) MEN1KMT2AMAPTCHEK1LMNA
SCHEMBL20571169 0.76 KMT2A (0.41) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL20571168 0.76 KMT2A (0.41) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL24683162 0.75 MAPT (0.45) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL31216537 0.75 CHEK1 (0.48) ALDH1A1KDM4ESMN1; SMN2CHEK1GAA
SCHEMBL24682625 0.72 MAPT (0.43) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL3561688 0.72 CHEK1 (0.48) ALDH1A1MAPTCHEK1POLBCYP1A2
SCHEMBL3561692 0.72 CHEK1 (0.42) MAPTCHEK1LMNACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200102331-A1 PENICILLIN-BINDING PROTEIN INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200102331-A1 PENICILLIN-BINDING PROTEIN INHIBITORS PEPD, BPGM, EBPL ALDH1A1 2794/4885MEN1 3629/4885KMT2A 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.